We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

DYMIND BIOTECHNOLOGY

Dymind designs, manufactures and sells a range of auto hematology analyzers and home ventilator. The company also off... read more Featured Products: More products

Download Mobile App





Dymind Presents Advanced Automatic Hematology Analysis Line

By LabMedica International staff writers
Posted on 06 Feb 2025

Dymind Biotechnology (Shenzhen, China) is presenting its comprehensive range of healthcare solutions at Medlab Middle East 2025, covering the fields of hematology, coagulation, immunoassay, POCT and veterinary. More...

Dymind is presenting the DH-8000 advanced hematology analysis workstation that provides a comprehensive testing solution for whole blood, capillary blood, body fluids, and pre-diluted samples. It is designed to enhance the user's experience in high-volume sample testing, by minimizing manual intervention and maximizing efficiency. Dymind is also showcasing the upgraded DH-800 auto hematology analyzer with AI technology that provides more accurate and efficient diagnosis. Also featured at the event is the MF1280 novel multiplex platform for allergy and autoimmunity testing that delivers rapid results for all tested items within a single test portfolio, significantly increasing diagnostic efficiency.

At the 2025 edition of Medlab Middle East, Dymind is highlighting the CA1200 fully automated coagulation analyzer that combines the optical and mechanical methods for clotting assays, while being able to intelligent switch from two methods when an abnormal sample is detected, to ensure both test accuracy and cost-effectiveness. In addition, Dymind is showcasing the innovative DP-H50 automatic 5-part hematology analyzer that integrates immunoassay and chemistry. With capabilities for joint tests in CBC, immunofluorescence, colloidal gold, and the chemistry module, the DP-H50 offers 5 test modes with single-package reagents to meet diverse demands. Among its veterinary solutions, Dymind is showcasing the automatic AI morphology analyzer, the D-wise, 5-part automatic hematology analyzer with RET, DM61 Vet, and DP-H10 Vet POCT hematology analyzer.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.